Scottish Biotech company secures £2.2m to accelerate rapid disease detection technology

Biotangents, a Scottish biotechnology business, has secured £2.2m of new funding made up from £1.6m from the UK Government’s Innovate UK innovation loans programme and a further £600k from a funding round lead by the investment syndicate Kelvin Capital and with Scottish Enterprise participation to support the development and roll-out of its ‘on farm’ rapid disease detection technology.

Read more HERE.